-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Fennec Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
- Fennec Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 27.3M shares, a 3.17% increase year-over-year.
- Fennec Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 26.6M shares, a 1.14% increase from 2022.
- Fennec Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 26.3M shares, a 1.03% increase from 2021.
- Fennec Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 26M shares, a 9.71% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)